Evidence map›Paper›PMID 23520489›Full record

Trial reportPloS one2013

Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy.

Daniel Westreich, Mhairi Maskew, Denise Evans, Cindy Firnhaber, Pappie Majuba, Ian Sanne

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Predictors of Safer Conception Practices Among HIV-Infected Women in Northern Nigeria.International journal of health policy and management · 2019
    Article
  4. Article
  5. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.Journal of acquired immune deficiency syndromes (1999) · 2017
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Daniel WestreichDepartment of Obstetrics and Gynecology and Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America. Erica.Pierce@ucdenver.edu
Mhairi Maskew
Denise Evans
Cindy Firnhaber
Pappie Majuba
Ian Sanne
University of the Witwatersrand · ZADuke University · USRight to Care · ZA

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Pregnancy and Response to Antiretroviral Therapy in South AfricaR00HD063961 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WESTREICH, DANIEL J · 2010 to 2012
$687k
NIAID NIH HHS P30 AI064518NIAID NIH HHS P30-AI-064518NICHD NIH HHS R00 HD063961NICHD NIH HHS R00-HD-06-3961PEPFAR
6 · The paper itself

Abstract

backgroundLittle is known about the impact of pregnancy on response to highly active antiretroviral therapy (HAART) in sub-Saharan Africa. We examined the effect of incident pregnancy after HAART initiation on clinical response to HAART.

methodsWe evaluated a prospective clinical cohort of adult women initiating HAART in Johannesburg, South Africa between 1 April 2004 and 31 March 2011, and followed up until an event, transfer, drop-out, or administrative end of follow-up on 30 September 2011. Women over age 45 and women who were pregnant at HAART initiation were excluded from the study. Main exposure was having experienced pregnancy after HAART initiation; main outcome was death and (separately) death or new AIDS event. We calculated adjusted hazard ratios (HRs) and 95% confidence limits (CL) using marginal structural Cox proportional hazards models.

resultsThe study included 7,534 women, and 20,813 person-years of follow-up; 918 women had at least one recognized pregnancy during follow-up. For death alone, the weighted (adjusted) HR was 0.84 (95% CL 0.44, 1.60). Sensitivity analyses confirmed main results, and results were similar for analysis of death or new AIDS event. Incident pregnancy was associated with a substantially reduced hazard of drop-out (HR = 0.62, 95% CL 0.51, 0.75).

conclusionsRecognized incident pregnancy after HAART initiation was not associated with increases in hazard of clinical events, but was associated with a decreased hazard of drop-out. High rates of pregnancy after initiation of HAART may point to a need to better integrate family planning services into clinical care for HIV-infected women.

Indexed as

Antiretroviral Therapy, Highly ActiveAcquired Immunodeficiency SyndromeAdultFemaleFollow-Up StudiesHIV SeropositivityHumansIncidencePregnancyPregnancy Complications, InfectiousRetrospective Studies

Identifiers

PMID23520489
PMCPMC3592862
OpenAlexW2064808732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.